publication venue for
- Association between menopausal hormone therapy use and mortality risk: a Swedish population-based matched cohort study. 2022
- Lessons learned from routine, targeted assessment of liquid biopsies for EGFR T790M resistance mutation in patients with EGFR mutant lung cancers.. 58. 2019
- Are fiducial markers useful surrogates when using respiratory gating to reduce motion of gastroesophageal junction tumors?. 55. 2016
- Central nervous system involvement in T-cell lymphoma: A single center experience.. 55. 2016
- Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial.. 53. 2013
- A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases.. 51. 2012
- Developing imaging strategies for castration resistant prostate cancer.. 50 Suppl 1. 2011
- Non-invasive molecular and functional imaging of cytosine deaminase and uracil phosphoribosyltransferase fused with red fluorescence protein.. 47. 2008
- Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elements.. 41. 2002
- Alterations in head and neck cancer occurring in HIV-infected patients--results of a pilot, longitudinal, prospective study.. 38. 1999
- Energy status parameters, hypoxia fraction and radiocurability across tumor types.. 34. 1995
- Circulating pancreatic polypeptide in patients with adenocarcinoma of the bile duct.. 32. 1993
- Bone marrow evaluation in small cell carcinoma of the lung.. 26. 1987
- Thymic malignancies treated with active scanning proton beam radiation and Monte Carlo planning: early clinical experience.. 60. 2021
- Keratoacanthomas associated with imatinib mesylate.. 50. 2010
- A petition for all patients with hidradenitis suppurativa to receive the HPV vaccine. 2020
- Treatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship. 2015
- Tumor markers in prostate cancer I: blood-based markers. 2011